@ShahidNShah
Doximity reports nearly $344M in revenue for fiscal 2022
Also: Pear Therapeutics reported $2.7 million in revenue for its first quarter compared with $1.3 million in Q4 2021.
Doximity, a networking platform for healthcare professionals, posted revenue of $93.7 million for its fourth quarter that ended on March 31, compared with $66.7 million in the prior-year quarter.
The company's net income came to $36.7 million compared with $21.5 million last year. Doximity also posted results for its fiscal 2022, bringing in $343.5 million compared with $206.9 million for fiscal 2021, which ended on March 31, 2021. It reported a full-year net income of $154.8 million, compared with $50.2 million.
For its upcoming quarter that will end June 30, Doximity posted revenue guidance between $88.6 million and $89.6 million. For the full year, which will end March 31, 2023, it predicts revenue between $454 million and $458 million.
During an earnings call, Doximity cofounder and CEO Jeff Tangney said the company surpassed two million registered members during the quarter and recorded record highs in use for its fax, e-signature and telehealth products. It also announced and wrapped up its acquisition of physician-scheduling and messaging app Amion during its Q4.
Continue reading at mobihealthnews.com
Make faster decisions with community advice
- Assisting providers in delivering frictionless care
- Cerner working with Elligo, Frenome on multiomics for early cancer detection
- NIH All of Us Research Program puts focus on precision nutrition
- Q&A: Why startups should work with the healthcare industry to improve maternal care
- 5 Benefits of Addressing Payment Integrity Before Payments Are Ever Made
Next Article
-
NIH All of Us Research Program puts focus on precision nutrition
A principal investigator of the landmark personalized medicine initiative explains how AI and other technologies are advancing its research – and could transform patient care. For some health …
Posted May 21, 2022 Clinical / Medical Research Nutritionists Precision Medicine